BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 37009801)

  • 1. BAP1 as a guardian of genome stability: implications in human cancer.
    Kwon J; Lee D; Lee SA
    Exp Mol Med; 2023 Apr; 55(4):745-754. PubMed ID: 37009801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles and mechanisms of BAP1 deubiquitinase in tumor suppression.
    Masclef L; Ahmed O; Estavoyer B; Larrivée B; Labrecque N; Nijnik A; Affar EB
    Cell Death Differ; 2021 Feb; 28(2):606-625. PubMed ID: 33462414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
    JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline BAP1 mutations predispose to malignant mesothelioma.
    Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M
    Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological Mechanisms and Clinical Significance of
    Carbone M; Harbour JW; Brugarolas J; Bononi A; Pagano I; Dey A; Krausz T; Pass HI; Yang H; Gaudino G
    Cancer Discov; 2020 Aug; 10(8):1103-1120. PubMed ID: 32690542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma.
    Cheung M; Talarchek J; Schindeler K; Saraiva E; Penney LS; Ludman M; Testa JR
    Cancer Genet; 2013 May; 206(5):206-10. PubMed ID: 23849051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Genetic and Genealogic Studies Uncover a Large BAP1 Cancer Syndrome Kindred Tracing Back Nine Generations to a Common Ancestor from the 1700s.
    Carbone M; Flores EG; Emi M; Johnson TA; Tsunoda T; Behner D; Hoffman H; Hesdorffer M; Nasu M; Napolitano A; Powers A; Minaai M; Baumann F; Bryant-Greenwood P; Lauk O; Kirschner MB; Weder W; Opitz I; Pass HI; Gaudino G; Pastorino S; Yang H
    PLoS Genet; 2015 Dec; 11(12):e1005633. PubMed ID: 26683624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
    Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting BAP1 with small compound inhibitor for colon cancer treatment.
    Kang M; Park SG; Lee SA; Kim S; Lee D; Shirbhate ME; Youn SY; Kim KM; Cha SS; Kwon J
    Sci Rep; 2023 Feb; 13(1):2264. PubMed ID: 36754982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
    Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
    J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
    Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
    JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant mesothelioma and constitutional BAP1 gene mutations].
    Neviere Z; Berthet P; Polycarpe F; Dubos-Arvis C; Dô P; Gervais R
    Rev Mal Respir; 2019 Feb; 36(2):241-248. PubMed ID: 30686559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive review of BAP1 tumor predisposition syndrome with report of two new cases.
    Rai K; Pilarski R; Cebulla CM; Abdel-Rahman MH
    Clin Genet; 2016 Mar; 89(3):285-94. PubMed ID: 26096145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.
    Betti M; Casalone E; Ferrante D; Romanelli A; Grosso F; Guarrera S; Righi L; Vatrano S; Pelosi G; Libener R; Mirabelli D; Boldorini R; Casadio C; Papotti M; Matullo G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2015 Jan; 54(1):51-62. PubMed ID: 25231345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
    Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
    Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.